SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

OSTX.A (OSTX.A) News

Track canonical SquawkNews coverage tagged to OSTX.A, OSTX.A. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol OSTX.A Asset market Sector Markets 90 days 1 Updated Sep 21, 2026, 10:33 AM UTC Open live news feed
M OS Therapies targets mid-Q4 2026 start for UK Phase 3 OST-HER2 trial OS Therapies plans to seek early market access for OST-HER2 in metastatic osteosarcoma via a U.K. conditional filing in the coming weeks, with MHRA set to lead the Project Orbis review. FDA alignment on an amended Phase EQUITY | Sep 21, 2026, 10:33 AM UTC